TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

US lifts pause on J&J vaccine, to start inoculation despite rare clot risk

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Washington, April 24

Advertisement

US health officials lifted an 11-day pause on Covid-19 vaccinations using Johnson & Johnson’s single-dose shot, after scientific advisers decided its benefits outweigh a rare risk of blood clot.

Advertisement

The government uncovered 15 vaccine recipients, who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalised.

Advertisement

Imran Khan, Pakistan Prime Minister

Pak PM for unified approach

I want to express solidarity with the people of India as they battle a dangerous wave of Covid-19. We must fight this global challenge confronting humanity together.

But ultimately Friday, the Food and Drug Administration and Centres for Disease Control and Prevention decided that J&J’s one-and-done vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative. “Above all else, health and safety are at the forefront of our decisions,” CDC Director Dr Rochelle Walensky said in a statement. “Our vaccine safety systems are working. We identified exceptionally rare events – out of millions of doses” of the J&J shot and will continue to monitor them.

The US decision — similar to how European regulators are rolling out J&J shot — comes after CDC advisers earlier Friday voted 10-4 to resume vaccinations but panelists made clear that they must come with warnings about the risk. The group debated but ultimately steered clear of outright age restrictions. “This is an age group that is most at risk (of the clotting) that is getting vaccine predominately to save other peoples’ lives and morbidity, not their own. And I think we have a responsibility to be certain that they know this,” said Dr Sarah Long of Drexel University College of Medicine, who voted against the proposal because she felt it did not go far enough in warning women. — AP

In Singapore Indian tests ve post jab

A 21-year-old Indian national, who had received both doses of the Covid-19 vaccine, is among the 36 new coronavirus cases reported in Singapore in the last 24 hours, according to a media report on Saturday. The man did not have any symptoms and was detected when he was tested on April 19 as part of the Health Ministry’s routine testing of foreign workers, the TODAY newspaper reported. The man’s pooled test result came back positive for Covid-19 and he was immediately isolated. PTI

Warning, risk and Clearance

New Covid strain detected in Lanka

Advertisement
Show comments
Advertisement